LIST OF TABLES
UU
TABLE 1 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA INFLAMMATORY DISEASE IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA NEUROTROPHIC KERATITIS (NK) IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA EPITHELIAL/LIMBAL STEM CELL DEFICIENCY IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA OTHERS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
TABLE 10 MIDDLE EAST AND AFRICA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA HOSPITALS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA HOMECARE IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA OTHERS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA HOSPITAL PHARMACIES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA RETAIL PHARMACIES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA ONLINE PHARMACIES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY COUNTRY 2018-2027 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
TABLE 30 MIDDLE EAST AND AFRICA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 37 UAE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
TABLE 38 UAE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 39 UAE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 40 UAE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
TABLE 41 UAE PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 42 UAE CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 43 UAE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 44 UAE PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 45 UAE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 46 UAE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 47 UAE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 48 SAUDI ARABIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
TABLE 49 SAUDI ARABIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 50 SAUDI ARABIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 51 SAUDI ARABIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
TABLE 52 SAUDI ARABIA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 53 SAUDI ARABIA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 54 SAUDI ARABIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 55 SAUDI ARABIA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 56 SAUDI ARABIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 57 SAUDI ARABIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 58 SAUDI ARABIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 59 SOUTH AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
TABLE 60 SOUTH AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 61 SOUTH AFRICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 62 SOUTH AFRICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
TABLE 63 SOUTH AFRICA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 64 SOUTH AFRICA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 65 SOUTH AFRICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 66 SOUTH AFRICA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 67 SOUTH AFRICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 68 SOUTH AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 69 SOUTH AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 70 ISRAEL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
TABLE 71 ISRAEL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 72 ISRAEL DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 73 ISRAEL DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
TABLE 74 ISRAEL PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 75 ISRAEL CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 76 ISRAEL MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 77 ISRAEL PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 78 ISRAEL MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 79 ISRAEL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 80 ISRAEL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 81 KUWAIT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
TABLE 82 KUWAIT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 83 KUWAIT DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 84 KUWAIT DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
TABLE 85 KUWAIT PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 86 KUWAIT CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 87 KUWAIT MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 88 KUWAIT PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 89 KUWAIT MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 90 KUWAIT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 91 KUWAIT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 92 EGYPT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
TABLE 93 EGYPT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 94 EGYPT DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 95 EGYPT DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
TABLE 96 EGYPT PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 97 EGYPT CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 98 EGYPT MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 99 EGYPT PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
TABLE 100 EGYPT MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 101 EGYPT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 102 EGYPT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 103 REST OF MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

LIST OF FIGURE

LIST OF FIGURES

FIGURE 1 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET : MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: SEGMENTATION
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET
FIGURE 11 NUMBER OF EYELID SURGERY IN U.S. IN 2018
FIGURE 12 AGEING WORLD POPULATION (NUMBER OF PERSONS AGED 60 YEARS OR OLDER IN MILLIONS)
FIGURE 13 AGEING NORTH AMERICA POPULATION (IN MILLION)
FIGURE 14 AGEING EUROPE POPULATION (IN MILLION)
FIGURE 15 AGEING ASIA-PACIFIC POPULATION (IN MILLION)
FIGURE 16 GDP PER CAPITA 2010, 2017 AND 2025:
FIGURE 17 INCREASING PREVALENCE OF PERSISTENT CORNEAL EPITHELIAL DEFECTS AND OTHER RELATED COMPLICATIONS AND RISING CASES OF EYE SURGERIES AND USAGE OF CONTACT LENSES IS DRIVING MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
FIGURE 18 INFLAMMATORY DISEASE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET IN 2020 & 2027
FIGURE 19 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES (2019)
FIGURE 20 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
FIGURE 21 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY CLINICAL CAUSES, CAGR (2020-2027)
FIGURE 22 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY CLINICAL CAUSES, LIFELINE CURVE
FIGURE 23 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE (2019)
FIGURE 24 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
FIGURE 25 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY TYPE, CAGR (2020-2027)
FIGURE 26 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 27 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER (2019)
FIGURE 28 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
FIGURE 29 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY END USER, CAGR (2020-2027)
FIGURE 30 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 31 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL (2019)
FIGURE 32 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
FIGURE 33 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027)
FIGURE 34 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: SNAPSHOT (2019)
FIGURE 36 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019)
FIGURE 37 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2020 & 2027)
FIGURE 38 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019 & 2027)
FIGURE 39 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY CLINICAL CAUSES (2020-2027)
FIGURE 40 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: COMPANY SHARE 2019 (%)